CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its insurance unit Aetna shows signs of recovery.Â
CVS, which operates the nation’s largest pharmacy chain, sees full-year adjusted profit coming in between $7.90 and $8.10 per share. That’s up from a previous guidance of $7.30 to $7.50 per share.Â
The company also expects revenue of at least $414 billion in 2026, up from its prior outlook of at least $405 billion.
In a release, CVS said the higher profit guidance reflects increases in its insurance and retail pharmacy segment, but noted that the company is maintaining a “cautious view” for the rest of the year amid high medical costs and potential challenges in the broader economy.
Shares of the healthcare giant rose 6% in premarket trading Wednesday. Â
All three of the healthcare giant’s business segments – insurance, pharmacy and health services —surpassed Wall…
